Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence

NCT02704416 is registered in ClinicalTrials.gov with Pacific Rim Electrophysiology Research Institute as lead sponsor.

NCT NCT02704416
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02704416 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablation in Brugada Syndrome for Prevention of VF - A Randomized, Multi-center Study of Epicardial Ablation in Brugada Syndrome Patients to Prevent Arrhythmia Recurrence
Lead sponsor
Pacific Rim Electrophysiology Research Institute
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2016
Completion date
November 13, 2024
Enrollment
200 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

brugada syndrome